Affiliation:
1. Division of Pediatric Neurology, Department of Neurology Washington University School of Medicine St Louis MO USA
2. Department of Neurological Sciences Rush University Chicago IL USA
3. Departments of Neurology, Radiology, Neuroscience, Physical Therapy, and Occupational Therapy Washington University School of Medicine St Louis MO USA
Abstract
AbstractAimTo determine the movement features governing expert assessment of gait dystonia severity in individuals with cerebral palsy (CP).MethodIn this prospective cohort study, three movement disorder neurologists graded lower extremity dystonia severity in gait videos of individuals with CP using a 10‐point Likert‐like scale. Using conventional content analysis, we determined the features experts cited when grading dystonia severity. Then, using open‐source pose estimation techniques, we determined gait variable analogs of these expert‐cited features correlating with their assessments of dystonia severity.ResultsExperts assessed videos from 116 participants (46 with dystonia aged 15 years [SD 3] and 70 without dystonia aged 15 years [SD 2], both groups ranging 10–20 years old and 50% male). Variable limb adduction was most commonly cited by experts when identifying dystonia, comprising 60% of expert statements. Effect on gait (regularity, stability, trajectory, speed) and dystonia amplitude were common features experts used to determine dystonia severity, comprising 19% and 13% of statements respectively. Gait variables assessing adduction variability and amplitude (inter‐ankle distance variance and foot adduction amplitude) were significantly correlated with expert assessment of dystonia severity (multiple linear regression, p < 0.001).InterpretationAdduction variability and amplitude are quantifiable gait features that correlate with expert‐determined gait dystonia severity in individuals with CP. Consideration of these features could help optimize and standardize the clinical assessment of gait dystonia severity in individuals with CP.
Funder
National Institutes of Health
National Institute of Neurological Disorders and Stroke
Acorda Therapeutics
Merz Pharmaceuticals
ACADIA Pharmaceuticals
Jazz Pharmaceuticals
Neurocrine Biosciences
National Center for Advancing Translational Sciences
National Institute on Aging
American Parkinson Disease Association
Subject
Neurology (clinical),Developmental Neuroscience,Pediatrics, Perinatology and Child Health
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献